[26T-pm] Drug design-1

[26T-pm04S] Development of chimeric molecules that degrade the estrogen receptor using decoy oligonucleotide ligands

○Miyako Naganuma^1,2, Nobumichi Ohoka², Haruna Tsujimura^1,2, Kenji Matsuno³, Mikihiko Naito⁴, Takao Inoue², Genichiro Tsuji², Yosuke Demizu^1,2 (1. Graduate School of Medical Life Science, Yokohama City University Yokohama City University, 2. National Institute of Health Sciences, 3. Graduate School of Engineering, Kogakuin University, 4. Graduate School of Pharmaceutical Sciences, The University of Tokyo)